Cartesian Therapeutics, Inc.
RNAC· Nasdaq
RNACCartesian Therapeutics, Inc.
Quarterly figures for Cartesian Therapeutics, Inc., with source filings when available.
46 quarters. Mar 31, 2015 to Jun 30, 2026. USD.
Cartesian Therapeutics, Inc. has filed its 10-Q within 30 to 39 days of period end across its last 8 quarters. The 10-K runs 61 to 74 days.
Cartesian Therapeutics, Inc. · CIK 1453687 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 6, 2026 · pre-market | Aug 6, 2026 | 37 d | 10-Q | $0.00 | — | $0.46 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| Apr 30, 2026 · pre-market |
| Apr 30, 2026 |
| 30 d |
| 10-Q |
| $0.00 |
| −100.0% |
| -$1.46 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 9, 2026 · pre-market | Mar 9, 2026 | 68 d | 10-K | $2.40M | — | — | |
| Q3 2025 | Sep 30, 2025 | Nov 6, 2025 · pre-market | Nov 6, 2025 | 37 d | 10-Q | $0.00 | — | -$1.38 | |
| Q2 2025 | Jun 30, 2025 | Aug 7, 2025 · pre-market | Aug 7, 2025 | 38 d | 10-Q | $0.00 | −100.0% | $0.50 | |
| Q1 2025 | Mar 31, 2025 | May 8, 2025 · pre-market | May 8, 2025 | 38 d | 10-Q | $400.00K | −93.2% | -$0.68 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Mar 13, 2025 · pre-market | Mar 13, 2025 | 72 d | 10-K | — | — | — | |
| Q3 2024 | Sep 30, 2024 | Nov 7, 2024 · pre-market | Nov 7, 2024 | 38 d | 10-Q | $0.00 | −100.0% | -$1.13 | |
| Q2 2024 | Jun 30, 2024 | Aug 8, 2024 · pre-market | Aug 8, 2024 | 39 d | 10-Q | $33.27M | +533.9% | $0.54 | |
| Q1 2024 | Mar 31, 2024 | May 8, 2024 · pre-market | May 8, 2024 | 38 d | 10-Q | $5.84M | −1.7% | -$10.50 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Mar 7, 2024 · pre-market | Mar 7, 2024 | 67 d | 10-K | $8.27M | −50.8% | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 13, 2023 | 44 d | 10-Q | $6.55M | −68.4% | -$1.74 | |
| Q2 2023 | Jun 30, 2023 | Aug 17, 2023 · pre-market | Aug 17, 2023 | 48 d | 10-Q | $5.25M | −86.6% | -$2.23 | |
| Q1 2023 | Mar 31, 2023 | — | May 4, 2023 | 34 d | 10-Q | $5.94M | −82.5% | -$4.24 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | — | Mar 2, 2023 | 61 d | 10-K | $16.80M | −43.9% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 3, 2022 · pre-market | Nov 3, 2022 | 34 d | 10-Q | $20.71M | −15.2% | -$0.05 | |
| Q2 2022 | Jun 30, 2022 | Aug 4, 2022 · pre-market | Aug 8, 2022 | 39 d | 10-Q | $39.27M | +99.7% | $0.06 | |
| Q1 2022 | Mar 31, 2022 | May 5, 2022 · pre-market | May 5, 2022 | 35 d | 10-Q | $34.00M | +207.7% | $0.08 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Mar 10, 2022 · pre-market | Mar 10, 2022 | 69 d | 10-K | $29.94M | +150.5% | — | |
| Q3 2021 | Sep 30, 2021 | Nov 9, 2021 · pre-market | Nov 9, 2021 | 40 d | 10-Q | $24.43M | +425.8% | -$0.16 | |
| Q2 2021 | Jun 30, 2021 | Aug 12, 2021 · pre-market | Aug 12, 2021 | 43 d | 10-Q | $19.66M | — | $0.00 | |
| Q1 2021 | Mar 31, 2021 | May 13, 2021 · pre-market | May 13, 2021 | 43 d | 10-Q | $11.05M | — | -$0.22 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | Mar 11, 2021 · pre-market | Mar 12, 2021 | 71 d | 10-K | $11.95M | +79.6% | — | |
| Q3 2020 | Sep 30, 2020 | Nov 5, 2020 · pre-market | Nov 5, 2020 | 36 d | 10-Q | $4.65M | — | -$0.09 | |
| Q2 2020 | Jun 30, 2020 | Aug 6, 2020 · pre-market | Aug 6, 2020 | 37 d | 10-Q | $0.00 | −100.0% | -$0.25 | |
| Q1 2020 | Mar 31, 2020 | May 7, 2020 · pre-market | May 7, 2020 | 37 d | 10-Q | $0.00 | −100.0% | -$0.21 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019 | Dec 31, 2019 | Mar 12, 2020 · pre-market | Mar 12, 2020 | 72 d | 10-K | $6.65M | +636.9% | -$0.28 | |
| Q3 2019 | Sep 30, 2019 | Nov 8, 2019 · pre-market | Nov 8, 2019 | 39 d | 10-Q | $0.00 | — | -$0.26 | |
| Q2 2019 | Jun 30, 2019 | Aug 8, 2019 · pre-market | Aug 8, 2019 | 39 d | 10-Q | $13.00K | — | -$0.37 | |
| Q1 2019 | Mar 31, 2019 | May 9, 2019 · pre-market | May 9, 2019 | 39 d | 10-Q | $10.00K | — | -$0.31 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018 | Dec 31, 2018 | Mar 15, 2019 · pre-market | Mar 15, 2019 | 74 d | 10-K | $903.00K | +5,211.8% | -$0.65 | |
| Q3 2018 | Sep 30, 2018 | Nov 8, 2018 · pre-market | Nov 8, 2018 | 39 d | 10-Q | $0.00 | −100.0% | -$0.71 | |
| Q2 2018 | Jun 30, 2018 | Aug 8, 2018 · pre-market | Aug 8, 2018 | 39 d | 10-Q | $0.00 | −100.0% | -$0.84 | |
| Q1 2018 | Mar 31, 2018 | May 9, 2018 · pre-market | May 9, 2018 | 39 d | 10-Q | $0.00 | −100.0% | -$0.71 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017 | Dec 31, 2017 | Mar 15, 2018 · pre-market | Mar 15, 2018 | 74 d | 10-K | $17.00K | −99.4% | -$0.88 | |
| Q3 2017 | Sep 30, 2017 | Nov 7, 2017 · pre-market | Nov 7, 2017 | 38 d | 10-Q | $27.00K | −97.4% | -$0.66 | |
| Q2 2017 | Jun 30, 2017 | Aug 11, 2017 · pre-market | Aug 11, 2017 | 42 d | 10-Q | $26.00K | −98.7% | -$0.85 | |
| Q1 2017 | Mar 31, 2017 | May 11, 2017 · after-hours | May 11, 2017 | 41 d | 10-Q | $137.00K | −93.4% | -$0.82 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016 | Dec 31, 2016 | Mar 27, 2017 · after-hours | Mar 28, 2017 | 87 d | 10-K | $2.93M | +37.3% | -$0.77 | |
| Q3 2016 | Sep 30, 2016 | Nov 10, 2016 · pre-market | Nov 10, 2016 | 41 d | 10-Q | $1.05M | −34.8% | -$0.43 | |
| Q2 2016 | Jun 30, 2016 | Aug 9, 2016 · pre-market | Aug 9, 2016 | 40 d | 10-Q | $2.02M | +63.2% | -$2.75 | |
| Q1 2016 | Mar 31, 2016 | — | — | — | — | $2.09M | +101.9% | -$4.52 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015 | Dec 31, 2015 | — | — | — | — | $2.13M | — | -$4.26 | |
| Q3 2015 | Sep 30, 2015 | — | — | — | — | $1.61M | — | -$3.50 | |
| Q2 2015 | Jun 30, 2015 | — | — | — | — | $1.24M | — | -$3.93 | |
| Q1 2015 | Mar 31, 2015 | — | — | — | — | $1.03M | — | -$3.43 | |
